Your browser doesn't support javascript.
loading
Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018.
Nyqvist, Jenny; Parris, Toshima Z; Helou, Khalil; Sarenmalm, Elisabeth Kenne; Einbeigi, Zakaria; Karlsson, Per; Nasic, Salmir; Kovács, Anikó.
Afiliação
  • Nyqvist J; Department of Surgery, Skaraborgs Hospital, Lidköping, Sweden. jenny.nyqvist@vgregion.se.
  • Parris TZ; Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. jenny.nyqvist@vgregion.se.
  • Helou K; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Cancer Center, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Sarenmalm EK; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Cancer Center, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Einbeigi Z; Research and Development Centre, Skaraborgs Hospital, Skövde, Sweden.
  • Karlsson P; Department of Oncology, Southern Älvsborg Hospital, Borås, Sweden.
  • Nasic S; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Kovács A; Research and Development Centre, Skaraborgs Hospital, Skövde, Sweden.
Breast Cancer Res Treat ; 184(1): 221-228, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32740808
ABSTRACT

PURPOSE:

Multiple primary malignancies (MPMs) caused by breast cancer treatment are well described, but only few studies to date describe which other previous primary malignancies (OPPMs) occur before breast cancer. The purpose of the present study was to evaluate the prevalence of OPPMs in patients with breast cancer between 2007 and 2018 in Western Sweden.

METHODS:

Patient selection was performed using both pathology reports at Sahlgrenska University Hospital (Sweden) and the Swedish Cancer Registry. All newly diagnosed breast cancer patients were screened for presence of OPPM.

RESULTS:

In total, 8031 breast cancer patients were diagnosed at Sahlgrenska University Hospital between 2007 and 2018. The prevalence of breast cancer patients with OPPMs (n = 414) increased from on average 2.6% to 8.2% during this 12-year period and ranged from 17 to 59 patients annually. The most striking increase in prevalence was found among the gynecological tumors (endometrium and ovarian adenocarcinomas), malignant melanomas and gastrointestinal malignancies. These findings were validated using data of the Swedish Cancer Registry.

CONCLUSIONS:

The overall survival rates for cancer patients have improved tremendously during the past 40 years, in part due to individually tailored therapies and screening programs. Our study revealed an increasing trend of OPPMs in breast cancer patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias Primárias Múltiplas Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias Primárias Múltiplas Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article